Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - COST OF REVENUE
Cost of Revenue SGMO - Sangamo Therapeutics, Inc.
222 M
LAST VALUE
384.48%
2 YEAR CAGR
14.04%
5 YEAR CAGR
19.61%
10 YEAR CAGR